Guanhao Biotech Co Ltd (300238) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.037x

Based on the latest financial reports, Guanhao Biotech Co Ltd (300238) has a cash flow conversion efficiency ratio of 0.037x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.84 Million ≈ $2.76 Million USD) by net assets (CN¥506.03 Million ≈ $74.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Guanhao Biotech Co Ltd for the company's overall valuation and market capitalisation.

Guanhao Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Guanhao Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guanhao Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guanhao Biotech Co Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Guanhao Biotech Co Ltd to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
ShaoYang Victor Hydraulics Co.Ltd
SHE:301079
N/A
Shandong Yuma Sun-shading Technology Corp. Ltd.
SHE:300993
0.018x
Groupe Guillin SA
PA:ALGIL
0.100x
Sports Toto Berhad
KLSE:1562
0.015x
Baolingbao Biology Co Ltd
SHE:002286
0.059x
Eupraxia Pharmaceuticals Inc
TO:EPRX
-0.037x
Kinko Optical Co Ltd
TW:6209
0.009x
Yulon Nissan Motor Co Ltd
TW:2227
-0.012x

Annual Cash Flow Conversion Efficiency for Guanhao Biotech Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Guanhao Biotech Co Ltd from 2007 to 2025. View Guanhao Biotech Co Ltd stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥506.03 Million
≈ $74.05 Million
CN¥71.47 Million
≈ $10.46 Million
0.141x +33.28%
2024-12-31 CN¥467.59 Million
≈ $68.42 Million
CN¥49.55 Million
≈ $7.25 Million
0.106x -10.70%
2023-12-31 CN¥456.26 Million
≈ $66.77 Million
CN¥54.15 Million
≈ $7.92 Million
0.119x -27.96%
2022-12-31 CN¥430.88 Million
≈ $63.05 Million
CN¥70.98 Million
≈ $10.39 Million
0.165x +0.70%
2021-12-31 CN¥748.16 Million
≈ $109.48 Million
CN¥122.39 Million
≈ $17.91 Million
0.164x +12.91%
2020-12-31 CN¥716.66 Million
≈ $104.87 Million
CN¥103.84 Million
≈ $15.19 Million
0.145x +10.24%
2019-12-31 CN¥704.14 Million
≈ $103.04 Million
CN¥92.55 Million
≈ $13.54 Million
0.131x +370.53%
2018-12-31 CN¥1.16 Billion
≈ $169.08 Million
CN¥32.28 Million
≈ $4.72 Million
0.028x +76.29%
2017-12-31 CN¥1.21 Billion
≈ $177.49 Million
CN¥19.22 Million
≈ $2.81 Million
0.016x -24.74%
2016-12-31 CN¥1.46 Billion
≈ $213.26 Million
CN¥30.68 Million
≈ $4.49 Million
0.021x -80.75%
2015-12-31 CN¥620.62 Million
≈ $90.82 Million
CN¥67.87 Million
≈ $9.93 Million
0.109x -11.18%
2014-12-31 CN¥531.61 Million
≈ $77.79 Million
CN¥65.45 Million
≈ $9.58 Million
0.123x +47.83%
2013-12-31 CN¥498.16 Million
≈ $72.90 Million
CN¥41.49 Million
≈ $6.07 Million
0.083x -23.01%
2012-12-31 CN¥454.11 Million
≈ $66.45 Million
CN¥49.12 Million
≈ $7.19 Million
0.108x +32.06%
2011-12-31 CN¥432.79 Million
≈ $63.33 Million
CN¥35.45 Million
≈ $5.19 Million
0.082x -64.81%
2010-12-31 CN¥144.99 Million
≈ $21.22 Million
CN¥33.76 Million
≈ $4.94 Million
0.233x +222.72%
2009-12-31 CN¥76.95 Million
≈ $11.26 Million
CN¥5.55 Million
≈ $812.33K
0.072x -44.41%
2008-12-31 CN¥37.01 Million
≈ $5.42 Million
CN¥4.80 Million
≈ $702.80K
0.130x +55.21%
2007-12-31 CN¥20.67 Million
≈ $3.02 Million
CN¥1.73 Million
≈ $252.86K
0.084x --

About Guanhao Biotech Co Ltd

SHE:300238 China Biotechnology
Market Cap
$428.75 Million
CN¥2.93 Billion CNY
Market Cap Rank
#13148 Global
#3903 in China
Share Price
CN¥11.05
Change (1 day)
+1.56%
52-Week Range
CN¥10.39 - CN¥17.85
All Time High
CN¥56.32
About

Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products in China. It offers NormalGEN and GrandNeuro, both a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. The company also provides Biological dura, a spinal patch; T… Read more